| Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283) |
|---|
| 09/27/2006 | CN1839204A Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 09/27/2006 | CN1276917C Method for synthesizing compound in condensed carbonyl group |
| 09/21/2006 | WO2006098308A1 Novel anthranilic acid derivative or salt thereof |
| 09/21/2006 | US20060211764 Cell activator, process for producing cell activator and apparatus therefor |
| 09/21/2006 | US20060211675 Preventives/remedies for urinary disturbance |
| 09/21/2006 | CA2602609A1 Novel anthranilic acid derivative or salt thereof |
| 09/20/2006 | EP1701695A1 Merocyanine derivatives for cosmetic use |
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/19/2006 | US7109381 Used in forming 1,3-dioxane compound |
| 09/19/2006 | CA2128509C Continuous process for manufacture of lactide polymers with improved purification methods |
| 09/14/2006 | WO2006095020A1 Heterocyclic-substituted alkanamides useful as renin inhibitors |
| 09/14/2006 | US20060205794 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant |
| 09/14/2006 | US20060205790 Medicinal arylethanolamine compounds |
| 09/14/2006 | US20060205719 Novel compounds having an antibacterial activity |
| 09/14/2006 | CA2600674A1 Heterocyclic-substituted alkanamides useful as renin inhibitors |
| 09/13/2006 | EP1700854A1 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivatives |
| 09/13/2006 | EP1097925B1 Novel benzoic acid derivatives and processes for the preparation thereof |
| 09/12/2006 | US7105708 Method for producing compounds having a CF2O bridge |
| 09/12/2006 | CA2120531C Dermatologic and/or cosmetic composition containing retinoidic compounds |
| 09/08/2006 | WO2006092623A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids |
| 09/08/2006 | CA2598785A1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids |
| 09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 09/06/2006 | EP1698618A1 Benzamide derivative |
| 09/06/2006 | EP1423357B1 Urea derivatives with antiproteolytic activity |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | CN1829706A 1,4-benzodioxane sulfonic acid compound and use thereof as electron-acceptor material |
| 09/06/2006 | CN1273215C Catalyst for carboxylic ester production and process for producing carboxylic ester |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/05/2006 | US7101915 P-terphenyl compounds |
| 09/05/2006 | US7101887 Treating neuropsycological diseases; schizophrenia, psychotic depression and mania |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194744 Illudin analogs useful as antitumor agents |
| 08/31/2006 | US20060194297 Stereoselective; reduction and esterification (in either order) of 2,3-dihydroxybutyrylalkanoic acid ester in the presence of a lipase or hydrolase, preferably of microorganism origin |
| 08/30/2006 | EP1694626A1 Purification process for lactide |
| 08/30/2006 | EP1412343B1 Compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 08/30/2006 | EP1202953B1 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/30/2006 | CN1826309A O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 08/29/2006 | US7098202 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/29/2006 | US7097887 Liquid crystal compounds |
| 08/29/2006 | CA2173616C Continuous process for the manufacture of lactide and lactide polymers |
| 08/24/2006 | US20060189678 4,5-dihydronaphtho[1,2-b]thiophene derivative |
| 08/24/2006 | US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/24/2006 | DE102005008021A1 New spiroketal-substituted cyclic ketoenol compounds used for combating animal parasites, undesired plant growth and/or undesired microorganisms |
| 08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 08/23/2006 | CN1821240A Process for preparing lactide using microwave radiation pressure reducing catalystic method |
| 08/23/2006 | CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative |
| 08/22/2006 | US7094594 Process for preparing optically active 2-[6-(hydroxy-methyl)-1,3-dioxan-4-yl] acetic acid derivatives |
| 08/17/2006 | WO2006085108A1 Awthranilic acid derivatives and their use in treatment of diseases of lipid metabolism, in particular dyslipidaemia |
| 08/17/2006 | WO2006048620A3 Benzo-1, 3-dioxanes for use in liquid crystal devices |
| 08/16/2006 | EP1689716A1 Biaryl sulfonamides and methods for using same |
| 08/16/2006 | EP1689702A1 Organic compounds |
| 08/16/2006 | EP1689380A2 Method for treating adamts-5-associated disease |
| 08/15/2006 | US7091349 Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution |
| 08/15/2006 | US7091219 Administering an effective amount of bis-sulfonamide hydroxyethyl-amino derivative to a HIV patient to prevent the viral replication |
| 08/10/2006 | WO2006055404A3 Compounds for targeting mechanisms implicated in the progression of stroke |
| 08/10/2006 | US20060178410 Preparation of N-{2-[4-(3-phenyl-4-methoxyphenyl)aminophenyl]ethyl}-2-hydroxy-2-(3-hydroxymethyl-4-hydroxyphenyl)ethylamine, for example; for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease |
| 08/10/2006 | US20060177621 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 08/09/2006 | EP1687268A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 08/03/2006 | WO2006081332A1 Substituted arylamine compounds and their use as 5-ht6 modulators |
| 08/03/2006 | WO2006081276A1 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity |
| 08/03/2006 | WO2005060456A8 Method for treating adamts-5-associate disease |
| 08/03/2006 | US20060173199 Stereoselective Ring Closure olefin Metathesis (RCM) reaction and Enzymatic Resolution (ER) for the production of optically pure synthetic intermediates during an organic synthesis; provides 3,6-dihydro-2H-pyrans |
| 08/03/2006 | US20060173058 Kcnq channel modulating compounds and their pharmaceutical use |
| 08/03/2006 | US20060172936 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/03/2006 | CA2595607A1 Substituted arylamine compounds and their use as 5-ht6 modulators |
| 08/03/2006 | CA2595542A1 3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity |
| 08/02/2006 | CN1267505C Fluorescent pigments |
| 08/02/2006 | CN1267438C antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 08/01/2006 | US7084285 reacting amino protected diols with 2-halogenoethyl dialkyl phosphites, then deprotecting the amine and condensing with 4-(3-trifluoromethyl-3H-diazirin-3-yl)-phenoxy substituted anhydrides, to form optically active sphingolipid metabolites, used for analyzing sphingomyelinase |
| 08/01/2006 | US7084168 Indoline derivatives |
| 08/01/2006 | CA2479571C Photodegradation of toxic organic contaminants |
| 08/01/2006 | CA2132843C Process for the production of cyclic esters from hydroxy acids and derivatives therefrom |
| 07/27/2006 | US20060167282 Process for industrially producing optically active 1,4- benzodioxane derivative |
| 07/26/2006 | EP0902003B1 Novel tetralone or benzopyranone derivatives and process for producing the same |
| 07/26/2006 | CN1807403A Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use |
| 07/26/2006 | CN1806919A Use of stannous benzoate as catalyst |
| 07/26/2006 | CN1266146C Glycolide production process, and glycolic acid oligomer for glycolide production |
| 07/26/2006 | CN1266118C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides |
| 07/25/2006 | US7081279 Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device |
| 07/20/2006 | WO2005051895A8 Organic compounds |
| 07/20/2006 | US20060160882 Indoline derivatives |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060159785 Grinding seeds to fine powder without precooling; defatting in hydrocarbon solvent (hexane or petroleum ether); extraction with medium polarity solvent (acetone) at 18 to 56 degrees C; evaporation of solvent; drying; and washing and drying crystalline silymarin extract. |
| 07/19/2006 | EP1680109A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/18/2006 | CA2341890C Oxygen-containing heterocyclic compounds |
| 07/18/2006 | CA2309771C New substitute dimeric derivatives, their preparation process and the pharmaceutical compositions that contain them |
| 07/13/2006 | WO2006072189A2 Spiro [bornyl - 2 , 4' - ( 1 , 3 -dioxanes) ] and their uses as fragrance ingredients |
| 07/13/2006 | US20060154977 Therapeutic molecules and methods-1 |
| 07/13/2006 | US20060154912 Isophtalic acid derivatives |
| 07/13/2006 | DE10209139B4 Tricyclische Verbindungen Tricyclic Compounds |
| 07/12/2006 | EP1678121A2 Tao kinase modulators and methods of use |
| 07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
| 07/12/2006 | CN1800145A Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 07/11/2006 | US7074837 Acetalization of aldehydes in the presence of acid catalysts, then aminating, cyanating, reducing and cyclization to form heterocyclic amines used as chemical intermediates or bactericides |
| 07/11/2006 | US7074836 Para-terphenyl compounds |
| 07/11/2006 | US7074464 low viscosity, high dielectric anisotropy, low threshold voltage, shortened response time; (E)-1,2,3,3,3-hexafluoro-1-(trans-4-(trans-4-pentylcyclohexyl)cyclohexyl)propene |
| 07/11/2006 | US7074462 fluorophenyl esters with positive dielectric anisotropy; liquid crystal displays; improved low temperature behavior and response times; reduced transition from smectic phase to nematic phase |
| 07/11/2006 | CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them |